Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia a with Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06289166
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 25
Not applicableUnknownNCT02554526
What this trial is testing

Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

Who this might be right for
Hemophilia A With Inhibitor
Nara Medical University 10
Post-approval studies (Phase 4)UnknownNCT03598725
What this trial is testing

Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China

Who this might be right for
Hemophilia A With Inhibitor
Beijing Children's Hospital 55
Not applicableLooking for participantsNCT05802836
What this trial is testing

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Who this might be right for
Severe Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor
Christoph Königs 100
Testing effectiveness (Phase 2)UnknownNCT04592692
What this trial is testing

A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

Who this might be right for
Hemophilia A With Inhibitor
Ascension Healthcare Development Limited 20
Not applicableStudy completedNCT01571934
What this trial is testing

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

Who this might be right for
Hemophilia A
Emory University 30
Large-scale testing (Phase 3)WithdrawnNCT02196207
What this trial is testing

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform

Who this might be right for
Severe Hemophilia A
Margaret Ragni
Early research (Phase 1)WithdrawnNCT03996486
What this trial is testing

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

Who this might be right for
Hemophilia
Bayer
Not applicableNot Yet RecruitingNCT07791836
What this trial is testing

Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study

Who this might be right for
Hemophilia AHemophilia
AryoGen Pharmed Co. 262
Large-scale testing (Phase 3)Ended earlyNCT06568302
What this trial is testing

The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial

Who this might be right for
Hemophilia aHemophilia BHemophilia a with Inhibitor+1 more
ApcinteX Ltd 15
Post-approval studies (Phase 4)Study completedNCT01800435
What this trial is testing

A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor

Who this might be right for
Hereditary Factor VIII Deficiency Disease With Inhibitor
Oslo University Hospital 6
Not applicableNot Yet RecruitingNCT07200609
What this trial is testing

The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia

Who this might be right for
Hemophilia A Without Inhibitor
Hacettepe University 20
Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60
Early research (Phase 1)Study completedNCT02270918
What this trial is testing

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Who this might be right for
Thrombosis
Thomas Jefferson University 12
Not applicableStudy completedNCT03619863
What this trial is testing

ATHN 7: Hemophilia Natural History Study

Who this might be right for
Hemophilia A With InhibitorHaemophilia A Without InhibitorHemophilia B With Inhibitor+1 more
American Thrombosis and Hemostasis Network 395
Post-approval studies (Phase 4)UnknownNCT04621916
What this trial is testing

Preventing Inhibitor Recurrence Indefinitely

Who this might be right for
Hemophilia AImmune Tolerance
Children's Hospital Los Angeles 52
Post-approval studies (Phase 4)Looking for participantsNCT06864975
What this trial is testing

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

Who this might be right for
Hemophilia a with Inhibitor
Runhui WU 110
Post-approval studies (Phase 4)Active Not RecruitingNCT04205175
What this trial is testing

Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab

Who this might be right for
Hemophilia A With Inhibitor
Children's Hospital Los Angeles 20
Testing effectiveness (Phase 2)Ended earlyNCT04548791
What this trial is testing

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

Who this might be right for
Factor VII DeficiencyGlanzmann ThrombastheniaHemophilia A With Inhibitor
Catalyst Biosciences 19
Not applicableStudy completedNCT01051076
What this trial is testing

Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center 3
Next Page